Resource Center
Resource Center
The new partnership will provide one six-month dose of injectable PrEP in Africa for every new PrEP patient who starts care through Freddie in Canada or the United States.
Read more
Unitaid and CHAI brought together more than 80 organizations from 28 countries for the Future of HIV Markets Forum, held in Nairobi, in June 2026. We've put together a report with the actions this group has committed to.
Read more
This is the current list of sessions with CHAI participation at AIDS 2026, which will take place virtually and in-person in Rio de Janeiro, Brazil from July 26 to 31, 2026.
Read more
New CHAI data from 2025 into early 2026: HIV testing, treatment, and prevention have shown little recovery from global funding cuts. Read the June 2026 memo.
Read more
How is lenacapavir PrEP rolling out globally? CHAI and WIts RHI track progress in early adopter countries and the path to generic market entry.
Read more
This toolkit provides practical guidance to integrate hepatitis, harm reduction, and triple elimination into HIV programs in ways that are policy-aligned, defensible, and scalable.
Read more
CHAI's latest market memo examines integrated HIV, syphilis, and hepatitis B screening in antenatal care across 16 countries and what it means for triple elimination.
Read more
26,000 children lost HIV treatment in 6 months. CHAI’s 2025 HIV Market Report shows funding cut impacts in 14 countries. Download data now.
Read more
This year's report checks in with our 2024-2028 strategy and our work to tackle persistent global health challenges even as the global health landscape has shifted.
Read more
CHAI has released the inaugural edition of its Triple Elimination Series, a set of market briefs examining market-shaping strategies to prevent vertical transmission of HIV, syphilis, and hepatitis B (commonly known as triple elimination). This first brief focuses on the introduction and scale-up of HIV/syphilis dual rapid diagnostic tests (RDTs), drawing on CHAI’s experience working...
Read more